DEM Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- DEM Biopharma's estimated annual revenue is currently $3.5M per year.
- DEM Biopharma's estimated revenue per employee is $77,500
Employee Data
- DEM Biopharma has 45 Employees.
- DEM Biopharma grew their employee count by 67% last year.
DEM Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO & COO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
DEM Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is DEM Biopharma?
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
keywords:N/A
N/A
Total Funding
45
Number of Employees
$3.5M
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $27M | 45 | -62% | $281.5M |
#2 | $7.6M | 45 | -6% | $128.2M |
#3 | $3.5M | 45 | 18% | N/A |
#4 | $12.7M | 45 | -18% | N/A |
#5 | $3.7M | 45 | 18% | N/A |